News roundup Tuesday, April 9

» Prolight Diagnostics collaboration with G&H | ITL drives development forward
» Lipum's CEO: "We act quickly and smartly without compromising on quality"
» Abliva wants to become a key player in mitochondrial medicine
» The contribution of sperm to solving involuntary infertility
» Diagonal Bios CEO: "Product on its way to market but we are valued as a start-up company"

Read BioStock's weekly newsletter for v.13 here.

Latest news of the day

The Board of Appeal gives Respirator right to patent. Read more.

PolarCool signs the first agreement in motorsport. Read more.

CLS receives other orders from National Institutes of Health Clinical Center. Read more.

Biosergen conducts a directed issue to guarantors. Read more.

Cereno Scientific announces extended patent protection in Europe for CS585 software. Read more.

Cantargia presents effects of nadunolimab in pancreatic cancer. Read more.

AegirBio A conditional agreement is entered into for a loan facility of SEK 45 million. Read moreAt the same time, the chairman announces that he intends to leave the board. Read more.

Studies show that two established treatments for heart attacks can be removed without worsening the outcome. Read more.

Abera Bioscience recruiting Ann-Christin Magnusson to the lab manager. Read more.

Immunovia on the way to model development study. Read more.

InDex Pharmaceuticals is proceeding with a recommended reverse acquisition. Read more.

Duearity announces that the goal of achieving break-even by the end of 2024 remains. Read more.

New study points to melatonin as a potential cure for chronic stress-induced depression-like behaviors. Read more.

Today is the last day of trading in Smell share to obtain the right to subscribe to the company's rights issue. Read more.

New health economic analysis confirms that Acarix cost-effectiveness in CADScor System. Read more.

Redwood Pharma changes the date for the annual general meeting and publication of the interim report. Read more.

By having invites you to a digital investor presentation in connection with the ongoing rights issue. Read more.

Jon Magne Asmyr flags in Thor Medical. Read more.

Demant informs about a reduction in share capital. Read more.

Novo Nordisk informs about share buybacks. Read more.

Annual Reports

Arctic Bioscience  Ascelia Pharma  Enzymatica  Neola Medical

Upcoming presentations

Calliditas Herantis Pharma